Kitao C, Tanaka H, Minami S, Omura S
J Antibiot (Tokyo). 1980 Jul;33(7):711-6. doi: 10.7164/antibiotics.33.711.
The biosynthetic relationship of the nanaomycins produced by Streptomyces rosa var. notoensis OS-3966 was studied by means of a bioconversion method using the antibiotic cerulenin, a specific inhibitor of fatty acid and polyketide biosyntheses. Nanaomycin D was considered to be the first component produced from the hypothetical intermediate "polyketide". It is proposed that the biosynthesis sequence for the nanaomycin is: nanaomycin D leads to nanaomycin A leads to nanaomycin E leads to nanaomycin B. Nanaomycin B can be converted to nanaomycin A by non-enzymatic dehydration; however, nanaomycin A is rapidly bioconverted to nanaomycin E, which is the major component synthesized by the nanaomycin-producing strain.
通过使用脂肪酸和聚酮生物合成的特异性抑制剂抗生素浅蓝菌素的生物转化方法,研究了玫瑰链霉菌诺托变种OS - 3966产生的那纳霉素的生物合成关系。那纳霉素D被认为是由假设的中间体“聚酮”产生的第一个组分。提出那纳霉素的生物合成顺序为:那纳霉素D产生那纳霉素A,那纳霉素A产生那纳霉素E,那纳霉素E产生那纳霉素B。那纳霉素B可通过非酶脱水转化为那纳霉素A;然而,那纳霉素A会迅速生物转化为那纳霉素E,那纳霉素E是那纳霉素产生菌株合成的主要组分。